Yusuf S. Althobaiti

Papers

1

Total Citations

4

H-Index

1

About

Yusuf S. Althobaiti is a pioneering researcher at the intersection of neuroscience, drug safety, and advanced biofabrication. His primary research areas include neurodevelopmental toxicology, 3D bioprinting, and the effects of widely prescribed drugs on embryonic brain development. Dr. Althobaiti’s most notable contribution is his groundbreaking 2024 study investigating the impact of pregabalin—a common medication for neurological disorders—on neuronal development. By employing ultrashort self-assembling peptides and a custom-built high-throughput robotic 3D bioprinting system, he created realistic three-dimensional cortical neuron cultures to model prenatal drug exposure. This innovative approach addresses a critical gap in understanding how maternal medication use may affect fetal brain development. His work has garnered early recognition, with his leading paper accumulating 4 citations, and demonstrates a powerful fusion of tissue engineering and neuropharmacology. Dr. Althobaiti’s research not only advances the field of developmental neuroscience but also provides a scalable, ethical platform for drug safety screening, positioning him as an emerging leader in translational neuroengineering and 3D cell culture technology.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Investigating the effect of pregabalin on neuronal development using ultrashort self-assembling peptides: Assessing 3D neuronal cultures with high throughput robotic 3D bioprinting
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago